A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

Abroad (travel likely)RecruitingPHASE1

Conditions

Kidney Disease · Renal Insufficiency Chronic · Kidney Failure, Chronic · Renal Impairment · Renal Insufficiency · End Stage Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Floridian Clinical Research, LLC, Miami Lakes, Florida, United States

    Study coordinator · 305.330.9977 Notes:
    Contact: Principal Investigator (Pedro Hernandez)
  • Omega Research Orlando LLC, Orlando, Florida, United States

    Study coordinator · 407-512-1054
    Contact: Principal Investigator (Kwabena Ayesu)
Study leads
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company